Epidermal Growth Factor Receptor Overexpression in Resected Pancreatic Cancer

Authors

Amit Mahipal, Thomas Jefferson UniversityFollow
Mary J. McDonald, Thomas Jefferson UniversityFollow
Agnieszka Witkiewicz, Thomas Jefferson UniversityFollow
Brian I. Carr, Thomas Jefferson UniversityFollow

Document Type

Poster

Publication Date

3-2011

Abstract

Conclusions:

Membrane EGFR overexpression is associated with poorer clinical outcomes in patients with pancreatic cancer receiving adjuvant therapy post resection.

Cytoplasmic EGFR overexpression is not associated with clinical outcomes.

Recommended Citation

Mahipal, Amit; McDonald, Mary J.; Witkiewicz, Agnieszka; and Carr, Brian I., "Epidermal Growth Factor Receptor Overexpression in Resected Pancreatic Cancer" (2011). Department of Medical Oncology Faculty Papers. Paper 3.
https://jdc.jefferson.edu/medoncfp/3